Jan 19, 2021, 11:30 AM by

Company forewarns the UK is risking fake COVID-19 vaccines and other medicines without a new system

Jan 19, 2021, 11:30 AM by

Jan 19, 2021, 11:29 AM by

Jan 19, 2021, 11:29 AM by

The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the appointment of a new senior team member. Eleanor Davies joins the company as Managing Partner.

Jan 19, 2021, 11:29 AM by

• New features include reaction-based library enumeration for novel molecule generation and optimisation • AI-integrated with seamless interface to Optibrium’s Artificial Intelligence platform, Cerella, to extract greater value from drug discovery data

Jan 19, 2021, 11:29 AM by

Raremark, the global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer to support the accelerated levels of growth the company is experiencing.

Jan 19, 2021, 11:29 AM by

Antibiotic Research UK is delighted to announce the appointment of Mr. Simon Dukes as Chair Designate of its Board of Trustees.

Jan 19, 2021, 01:00 AM by User Not Found

Bio-IT World | TRENDS FROM THE TRENCHES—Dan Stanzione has been working at the Texas Advanced Computing Center in Austin for three quarters of its 19-year tenure. Now the executive director and associate vice president of research, Stanzione runs TACC as both the research computing arm of the University of Texas as well as an independent National Science Foundation-funded supercomputing center. He sat down with Stan Gloss to talk about big compute, pandemics, and technology trends.

Jan 15, 2021, 17:42 PM by User Not Found

Bio-IT World | Oxford Nanopore Technologies and NVIDIA announced a collaboration this week to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION. Partnering the NVIDIA A100 Tensor Core GPU technology with the PromethION device aims to deliver the world’s most powerful sequencer that supports real-time analyses at scale and can also analyze any length fragment of DNA/RNA.

Jan 15, 2021, 11:48 AM by User Not Found

Bio-IT World | At the J.P. Morgan Healthcare Conference yesterday, PacBio’s new CEO, laid out a route to the clinic for PacBio’s HiFi sequencing reads, and set a 2021 goal of expansion across the business: improving commercial footprint, driving product development pipelines, and establishing market leadership in whole-genome clinical sequencing.

Jan 14, 2021, 18:13 PM by User Not Found

Bio-IT World I Single-dose nanoparticle vaccine triggers strong immune response in mice, mapping the unique structure of SARS-CoV-2 ORF8 protein, COVID-19 may eventually become as mild as common cold. Plus: Human lung bronchioalveolar tissue model successfully demonstrates viral replication along with potential therapy and mitochondria one of the first lines of defense.

Jan 14, 2021, 01:00 AM by User Not Found

Bio-IT World | Serge Saxonov, CEO and co-founder of 10x Genomics, painted a rosy picture of the future of single-cell technologies at the J.P. Morgan Healthcare Conference. And 10x has the product suite to enable that future, including a new version of the Chromium platform, a higher resolution version of the Visium platform, a coming In Situ platform, a wider rollout of the 10x Cloud, and new tools to address sample prep and cost.

Jan 13, 2021, 16:28 PM by User Not Found

Bio-IT World | Pacific Biosciences and Invitae today announced a multi-year collaboration to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate HiFi sequencing to expand Invitae’s whole genome testing capabilities.

Jan 13, 2021, 14:27 PM by User Not Found

Bio-IT World | As aging researchers are aware, “birthday candles are not a good guide” to either human health or longevity. But there is an abundance of clues in the genome and, as suggested by studies in animals, some of age-related damage is reversible by removing or reprogramming problematic cells or blocking the activity of key proteins.

Jan 11, 2021, 18:50 PM by User Not Found

Bio-IT World | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, made partnership announcements, and launched Illumina Connected Analytics, an expanding software analytics platform. deSouza did not announce any new sequencing platforms, though he teased updates coming in 2021.

Jan 11, 2021, 14:35 PM by

Jan 11, 2021, 14:35 PM by

The EMA will use Panalgo’s Instant Health Data (IHD) platform to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.

Jan 11, 2021, 13:27 PM by User Not Found

Bio-IT World | Kicking off news from the J.P. Morgan 39th Annual Healthcare Conference, Seqster announced the release of Seqster Platform v7.1 on the Microsoft Azure cloud this morning.

Jan 8, 2021, 01:00 AM by User Not Found

Bio-IT World I New hybrid approach identifies existing drugs that could be repurposed to treat SARS-CoV-2 and Cellid signs research contract with the International Vaccine Institute to expedite clinical development of “AdCLD-CoV-19” COVID-19 vaccine. Plus: Illumina and Helix will track the emergence and prevalence of new strains, including the highly transmissible B.1.1.7 variant.

Jan 7, 2021, 11:26 AM by

Panthera’s clinical trial sites are helping to evaluate an alternative AstraZeneca vaccine for people who are unable to have the currently approved Covid-19 vaccines. The treatment is aimed at helping those people with a compromised immune system, who cannot be vaccinated, vaccine hesitant and those who are unlikely to respond to a vaccination.